Reported 0 shares, down 15,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
50 managers reported BIOMARIN PHARMACEUTICAL INC for Q1 2015.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT DE | Reduced | 40,940,000 | -18,707,000 | 0.87% | $60,367,000 | 6 qtrs |
| OAKTREE CAPITAL MANAGEMENT LP | Reduced | 33,083,000 | -3,000,000 | 0.52% | $49,182,000 | 6 qtrs |
| Lombard Odier Asset Management Europe Ltd | New | 31,500,000 | +31,500,000 | 3.67% | $46,854,000 | 4 qtrs |
| MACKAY SHIELDS LLC | Reduced | 23,703,000 | -389,000 | 1.87% | $35,365,000 | 6 qtrs |
| SHENKMAN CAPITAL MANAGEMENT INC | Reduced | 17,422,000 | -2,726,000 | 2.87% | $25,704,000 | 4 qtrs |
| LOOMIS SAYLES & CO L P | Reduced | 196,707 | -3,770 | 0.07% | $24,514,000 | 6 qtrs |
| BLACKROCK ADVISORS LLC | Added | 13,931,000 | +536,000 | 0.02% | $20,731,000 | 6 qtrs |
| Invesco Ltd | Unchanged | 12,517,000 | 0 | < 0.01% | $18,627,000 | 6 qtrs |
| BAKER BROS ADVISORS LP | Reduced | 12,228,000 | -272,000 | 0.15% | $17,970,000 | 6 qtrs |
| Bank of America Corporation | New | 10,479,000 | +10,479,000 | < 0.01% | $15,594,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- March 31, 2015
- Filed
- May 14, 2015
- Filing type
- 13F-HR
- Position type
- BC
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.